Research article · 17 Jul 2026
Conference abstractPublished 28 Apr 2016
Effects of nalbuphine as an adjuvant on levobupivacaine induced caudal analgesia in children undergoing lower abdominal surgeries: Randomized controlled double blinded study
Cairo University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: This double-blinded, randomized, controlled study was designed to explore and compare the possible effects of nalbuphine on the clinical profile of levobupivacaine-induced caudal block in children undergoing lower abdominal surgeries. Materials & Methods: The study included 40 patients (1âÂ?Â?9 years) randomised to receive 1ml/ kg levobupivacaine 0.25% plus 0.5 ml normal saline (control(L) group n=20) or 1ml/ kg levobupivacaine 0.25% plus 0.5 ml nalbuphine (0.1 mg/kg) (nalbuphine (LN) group n=20) after induction of anaesthesia. All patients received a standard anaesthetic including: sevoflurane induction, Isoflurane maintenance, and patients were breathing spontaneously. The primary outcome was time to first request for rescue postoperative analgesia. Haemodynamic changes, objective sedation score based on eye-opening and AIIMS pain discomfort scale (All India Institute of Medical Sciences); were recorded at predetermined intervals. Results: Patients characteristics were comparable in the two groups. The time to first request to rescue analgesic was longer in the nalbuphine group compared to the control; 11.2 (1.6), 5.9 (1.0) h, respectively (P<0.01). AIIMS pain score was significantly higher in the control group at 4, 6 and 12 hours postoperatively; while the nalbuphine group had higher sedation scores at 30 min and 1 hour post-operatively. Haemodynamics were comparable in the two groups and nalbuphine use was not associated with any observed side effects. Conclusion(s): Nalbuphine as adjuvant to levobupivacaine induced caudal analgesia is safe in children undergoing lower abdominal surgeries and prolongs duration of postoperative analgesia. However it may cause early postoperative sedation, yet without respiratory depression.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Developing Drugs.
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Heba Nassar”
- BylineArticles whose byline prints “Mohammad Farouk”
- BylineArticles whose byline prints “Riham Hussein”
- BylineArticles whose byline prints “Tamer Fathy”
